Peptide

COSRX Returns to TikTok with the #PatThePeptide Campaign, Highlighting the Accessibility of Peptide Skincare

Retrieved on: 
Thursday, March 7, 2024
Cream, Collection, Absorption, Skin, Hyperpigmentation, Peptide, Vitamin C, Vitamin, Serum, Vaccine

The #PatThePeptide campaign aims to showcase and emphasize how COSRX's popular product, The 6 Peptide Skin Booster Serum , has made skincare more accessible than ever.

Key Points: 
  • The #PatThePeptide campaign aims to showcase and emphasize how COSRX's popular product, The 6 Peptide Skin Booster Serum , has made skincare more accessible than ever.
  • Easy Derm Skincare: The serum seamlessly integrates into all skincare routines, offering comfort and ease of use without fear of irritation.
  • Skincare for All: COSRX products are clinically verified, hypoallergenic, and suitable for all skin types, including sensitive skin.
  • Additionally, the top 90 winners will receive The 6 Peptide Skin Booster Serum and a randomly selected COSRX product from COSRX's collection.

Exclusive New Peptide-Infused Hair Care Brand, V&Co. Beauty, Launches in Major Retailers Across the Nation

Retrieved on: 
Tuesday, March 5, 2024
Head, Collection, Thickening agent, Paraben, Beauty, Dicarboxylic acid, Individual, Albertsons, Vitamin, Skin, Entrepreneurship, Skin care, Sulfate, Health, Peptide, Walmart, Safeway, Family, Protein, Research, Scalp, Cosmetics

WAYZATA, Minn., March 5, 2024 /PRNewswire/ -- A cutting edge innovation in peptide-infused hair care has arrived and is launching in-store and online at national and regional retailers, including Target and Walmart. V&Co. Beauty is a first-ever collection of shampoos and conditioners, powered by scientific innovation and rooted in targeted hair health that caters to the distinctive needs of each type and texture. The curated vegan and cruelty-free product selection allows consumers to level up their routine with four targeted shampoo and conditioner options: Wavy, Straight, Curly, and Thickening, empowering healthy hair journeys and inspiring individuality.

Key Points: 
  • Peptides have become a staple across skin care and supplements because they can help deliver real, unrivaled results.
  • However, there have been little to no options in the hair care aisle that leveraged their deeply reparative benefits…until now.
  • The Redmond family are serial entrepreneurs within the hair care industry, having founded beloved household name brands like Aussie Hair Care and Renpure.
  • Mike and Tom noticed peptides sweeping skin care aisles and were inspired to research their benefits for hair, alongside their seasoned scientific team.

BioVaxys Announces Allowance of DPX-Related Patent for Japan and Filing of Additional International Patent Applications

Retrieved on: 
Tuesday, March 5, 2024
RSV, Cancer, Messenger, Infection, FRA, Patent, APC, PCT, Patent Cooperation Treaty, HSV, Antibody, IMV, Peptide, Antigen, Protein, Intellectual property, Zika virus, Immune system, Vaccine

This Patent was part of the extensive Intellectual Property portfolio recently acquired by BioVaxys from the former IMV, Inc.

Key Points: 
  • This Patent was part of the extensive Intellectual Property portfolio recently acquired by BioVaxys from the former IMV, Inc.
  • This Patent has already been issued in the US, and is currently pending in the EU.
  • BioVaxys also is pleased to announce it filed an international patent application through the Patent Cooperation Treaty ("PCT") from two pending patent applications in the US related to methods of formulating DPX™ compositions that comprise both a lipid-based adjuvant (i.e.
  • The PCT is a patent treaty with more than 150 member countries, makes it possible to seek patent protection for an invention simultaneously in a large number of countries by filing a single "international" patent application instead of filing several separate national or regional patent applications.

Revision Skincare® Launches Skincare-first Sunscreen, Intellishade® TruPhysical Clear

Retrieved on: 
Friday, March 1, 2024
Collection, Absorption, Ageing, Skin, Peptide, Vitamin C, Antioxidant, Trial of the century, Nutritional science, Cosmetics

DALLAS, March 1, 2024 /PRNewswire/ -- Revision Skincare®, a leading medical-grade professional skincare brand, today announces the launch of its newest innovation in their Intellishade® collection, TruPhysical Clear. Designed to benefit all skin tones and types, including sensitive skin, this anti-aging moisturizer with Broad-Spectrum SPF 50 corrects, protects, brightens and hydrates skin without leaving a white cast or shine.

Key Points: 
  • DALLAS, March 1, 2024 /PRNewswire/ -- Revision Skincare®, a leading medical-grade professional skincare brand, today announces the launch of its newest innovation in their Intellishade® collection, TruPhysical Clear.
  • Intellishade TruPhysical Clear joins Revision Skincare's powerhouse Intellishade collection which consists of Intellishade Original, Intellishade TruPhysical, Intellishade Matte and Intellishade Clear.
  • TruPhysical Clear brings consumers an exciting new option within the larger collection, especially those with sensitive skin or who have received a recent in-office skin procedure.
  • "I've been testing Intellishade TruPhysical Clear for the past few months and love how easily it blends into the skin," says Dr. Karan Lal, Board-Certified Dermatologist, who helped guide the development of Intellishade TruPhysical Clear.

Cyclic Peptide Synthesis for Drug Discovery: Uses, Benefits and Challenges, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Thursday, February 29, 2024
Compound, Peptide, Drug discovery, Kinetics, Fine chemical

TORONTO, Feb. 29, 2024 /PRNewswire-PRWeb/ -- In 2023, peptide-based drugs continued to gain prominence, and three out of six new peptide drug approvals were for cyclic peptides due to their favorable drug properties, such as cell permeability, proteolytic stability and binding kinetics. Cyclic peptides, however, often result in challenging projects due to the difficulty of synthesis or time constraints.

Key Points: 
  • The attendees will also gain insights into cyclic peptides and potential issues in using them for drug discovery.
  • Moreover, they will get to learn about issues with ring strain and what to look for/be aware of when working with cyclic peptides.
  • This session is ideal for anyone interested in cyclic peptide synthesis and its role in drug discovery.
  • Register for this webinar to understand the challenges and strategies for synthesizing cyclic peptides and understand its role in drug discovery.

DOVE LAUNCHES BOND STRENGTH, AN END-TO-END COLLECTION TO REPAIR AND CARE FOR YOUR HAIR

Retrieved on: 
Wednesday, February 28, 2024
Anxiety, Woman, Research, Element, Peptide, Primary energy, PETA, Cosmetics

TORONTO, Feb. 28, 2024 /CNW/ - Today, Dove announced the launch of its Dove Bond Strength regimen, an end-to-end solution to visibly repair and restore your hair.

Key Points: 
  • TORONTO, Feb. 28, 2024 /CNW/ - Today, Dove announced the launch of its Dove Bond Strength regimen, an end-to-end solution to visibly repair and restore your hair.
  • Paraben-free, vegan, PETA-approved and suitable for all hair types, the range offers visible repair and restoration for healthier, more radiant hair.
  • The Bond Strength collection includes:
    Dove Bond Strength Shampoo & Conditioner: strengthening shampoo and conditioner, formulated with a unique blend of technologies, with peptides and Bio-Protein Care™.
  • Dove Bond Strength is not just a hair care range, it is an end-to-end solution, so women can feel comfortable, confident, fulfilled and beautiful.

Waters Announces Seamless HPLC/UPLC Data Bridge for Light Scattering, Integrating Essential Instruments for Large Molecule Characterization

Retrieved on: 
Monday, February 26, 2024
CONNECT, Wyatt Technology Corporation, Acquisition, SAN, Drug development, Data collection, HPLC, QA/QC, WAT, Waters Corporation, UV, Risk, MALS, Peptide, Protein, Wyatt (surname), Software, Fine chemical

SAN DIEGO, Feb. 26, 2024 /PRNewswire/ -- Pittcon 2024 – Waters Corporation (NYSE:WAT) announced HPLC CONNECT software, an all-in-one software platform that enables full digital synchronization between Waters high- and ultra-performance liquid chromatography (HPLC/UPLC) systems and multi-angle light-scattering instruments (MALS) from its Wyatt Technology™ portfolio. The software delivers ease-of-use, greater efficiency, and higher confidence for scientists performing size exclusion chromatography and MALS (SEC-MALS) analyses for complex and critical biopharmaceutical innovations, including antibody drug conjugates, other complex protein conjugates, and gene therapies.

Key Points: 
  • Waters now enables seamless connectivity between its liquid chromatography (LC) systems and multi-angle light-scattering instruments (MALS) for improved ease-of-use, efficiency, and data confidence in characterizing large molecules.
  • HPLC CONNECT™ software accelerates precise characterization of complex molecules for the development of biologic drugs, including antibody drug conjugates, other complex protein conjugates, and gene therapies.
  • HPLC CONNECT software greatly simplifies characterization of large molecules – a critical step in developing biologics.
  • Waters HPLC CONNECT software removes a significant amount of labor, reduces risk of human error, and delivers unmatched confidence in the data generated during analysis."

Waters Announces Seamless HPLC/UPLC Data Bridge for Light Scattering, Integrating Essential Instruments for Large Molecule Characterization

Retrieved on: 
Monday, February 26, 2024
CONNECT, Wyatt Technology Corporation, Acquisition, SAN, Drug development, Data collection, HPLC, QA/QC, WAT, Waters Corporation, UV, Risk, MALS, Peptide, Protein, Wyatt (surname), Software, Fine chemical

SAN DIEGO, Feb. 26, 2024 /PRNewswire/ -- Pittcon 2024 – Waters Corporation (NYSE:WAT) announced HPLC CONNECT software, an all-in-one software platform that enables full digital synchronization between Waters high- and ultra-performance liquid chromatography (HPLC/UPLC) systems and multi-angle light-scattering instruments (MALS) from its Wyatt Technology™ portfolio. The software delivers ease-of-use, greater efficiency, and higher confidence for scientists performing size exclusion chromatography and MALS (SEC-MALS) analyses for complex and critical biopharmaceutical innovations, including antibody drug conjugates, other complex protein conjugates, and gene therapies.

Key Points: 
  • Waters now enables seamless connectivity between its liquid chromatography (LC) systems and multi-angle light-scattering instruments (MALS) for improved ease-of-use, efficiency, and data confidence in characterizing large molecules.
  • HPLC CONNECT™ software accelerates precise characterization of complex molecules for the development of biologic drugs, including antibody drug conjugates, other complex protein conjugates, and gene therapies.
  • Waters HPLC CONNECT software removes a significant amount of labor, reduces risk of human error, and delivers unmatched confidence in the data generated during analysis."
  • HPLC CONNECT software supports select Waters™ LC systems including the ACQUITY™ Premier, Arc Premier, and Arc Systems.

CATUG and Crystal Bio Establish Strategic Partnership, Launching "CATUG-Crystal" Joint Lab Dedicated to Advanced Nucleic Acid Analytical Services

Retrieved on: 
Thursday, February 22, 2024
Therapy, Messenger, Drug development, Spacecraft, Antibody, RNA, Peptide, Dicarboxylic acid, Organization, Protein, DNA, CMC, Partnership, Fine chemical

and CRANBURY, N.J., Feb. 22, 2024 /PRNewswire/ -- CATUG Inc. (CATUG) and Crystal Bio, a member of Crystal Pharmatech, announced today a long-term strategic partnership to provide advanced nucleic acid-based drug analytical services.

Key Points: 
  • and CRANBURY, N.J., Feb. 22, 2024 /PRNewswire/ -- CATUG Inc. (CATUG) and Crystal Bio, a member of Crystal Pharmatech, announced today a long-term strategic partnership to provide advanced nucleic acid-based drug analytical services.
  • CATUG, a distinguished global entity specializing in integrated nucleic acid and drug delivery CRDMO services, is combining capabilities with Crystal Bio, a premier provider of analytical services for biologics in CMC, preclinical development, and clinical stages.
  • The two specialized organizations will provide clients with comprehensive nucleic acid services and analytical solutions in the North American market.
  • CATUG and Crystal Bio are confident that by combining the local analytical prowess of Crystal Bio with CATUG's proficient expertise in integrated nucleic acids analytical platforms, CATUG-Crystal will deliver best-in-class analytical services and drive advancements in nucleic acid-based drug development to the North American market.

Evolved By Nature Announces Distribution Agreement with Barentz

Retrieved on: 
Wednesday, February 21, 2024
Nature, Biotechnology, Skin, Ceramide, Peptide, Sustainable Development Goals, Petroleum, Dermatitis, Irritation, Beauty, Fine chemical

Distribution will be throughout the US and Canada.

Key Points: 
  • Distribution will be throughout the US and Canada.
  • "At Evolved By Nature, we understand that biotechnology is very exciting to the skincare, personal care and cosmetics industries – but that it's also looked at with some hesitation.
  • Biotech often engineers natural look-alike ingredients, which don't meet consumer demand for truly effective and sustainable ingredients.
  • We're proud to have developed a platform of natural ingredients using biotechnology to harvest the power of nature rather than attempting to mimic it in biosynthetic ways.